https://doi.org/10.1351/goldbook.12658
Drug having a similar mechanism of action to an existing drug.
Note: Compounds may be of the same or different chemical class. A therapeutic advantage over first-in-class drugs must be demonstrated for regulatory approval.
See also: analogue, analogue-based drug design